Earnings6 reported quarters · next on Feb 16, 2027
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q3 FY2026reported Oct 27, 2026
$1.46
$1.29
$3.3B
$2.8B
EPS beatRevenue beat
Q2 FY2026reported Jul 28, 2026
$1.33
$1.13
$3.0B
$3.0B
EPS beatRevenue miss
Q1 FY2026reported Apr 28, 2026
$3.83
$3.69
$4.4B
$3.5B
EPS beatRevenue beat
Q4 FY2025reported Feb 17, 2026
$2.00
$1.87
$3.3B
$2.9B
EPS beatRevenue beat
Q3 FY2025reported Oct 28, 2025
$0.97
$0.90
$3.0B
$2.7B
EPS beatRevenue beat
Q2 FY2025reported Jul 29, 2025
$1.10
$1.14
$3.7B
$2.5B
EPS missRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Firms' latest targets on EXE range from $107 to $141.
Lowest: Barclays, Aug 17Highest: Raymond James, Oct 5
Past year Each firm's latest target, newest first
Each firm's latest price target on EXE, newest first
Firm
Rating
Target
Action
Date
Goldman Sachs
Buyrated Aug 26, 2026
$117
Target set
UBS
Buy
$120
Cut from $122
Scotiabank
Outperform
$111
Initiated
Mizuho
Outperform
$138
Target set
Raymond James
Strong Buy
$141
Cut from $147
Truist Securities
Buy
$120
Target set
Bernstein
Outperform
$127
Target set
Jefferies
Buy
$136
Target set
Stifel
Buy
$135
Initiated
Morgan Stanley
Overweight
$129
Cut from $131
Johnson Rice
Accumulate
$125
Target set
Barclays
Equal Weight
$107
Cut from $110
Roth Capital
Not stated
$93
Target set
Wolfe Research
Not stated
$114
Target set
Wells Fargo
Not stated
$123
Target set
Stephens
Overweight
$146
Target set
Piper Sandler
Overweight
$137
Target set
Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice. A rating with its own date under it is the firm's latest from the past 120 days, where the note stated none.
The range is each listed firm's latest target from the last 90 days, lowest to highest. It is not an average. 4 other firms rated EXE in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 11, 2026.
13F filings13F positions as of Jun 30, 2026
Institutional holders
853 institutions reported Expand Energy shares in 13F filings for Jun 30, 2026.
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
2 of the 97 fund managers we track list EXE shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
STOCK Act10 disclosures of 10 on record · median 27d of the 45 allowed
Congress trades in EXE
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
-18.1%since the tradeEstimated entry price $107.35, close on Fri Mar 21, 2025Current price $87.94, close on Tue Nov 10
Mar 21, 2025
Apr 10, 2025
20d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
The largest estimated position is in the $1,001 - $15,000 band. Estimate, as of Nov 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on EXE show and how current they are.
Are insiders buying or selling EXE?
Across the 8 most recent open-market filings shown here, 8 were purchases and 0 were sales.
Which members of Congress have traded EXE?
Ro Khanna, Julia Letlow, Gilbert Ray Cisneros, Jr. and Robert Bresnahan disclosed EXE transactions in the filings shown here.
Which members of Congress hold EXE?
1 member of Congress reports a position in EXE in the estimate we hold as of Nov 10, 2026. The estimated position belongs to Gilbert Ray Cisneros, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is EXE in the S&P 500 or the Nasdaq 100?
Expand Energy Corporation is a current member of the S&P 500, per the membership list we hold as of Nov 11, 2026. Current members of either index get a page here whatever their filing history.
How quickly are EXE trades disclosed?
Insider filings on this page reached the public a median of 0 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.